bromodeoxyuridine has been researched along with Animal Mammary Carcinoma in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 6 (85.71) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asamoto, M; Ogawa, K; Shirai, T; Takeshita, F | 1 |
| Dierendonck, JH; Nederbragt, H; Rutteman, GR; Teske, E; van Garderen, E; Zacchetti, A | 1 |
| Arendt, LM; Gilchrist, K; Rose-Hellekant, TA; Sandgren, EP; Schroeder, MD; Schuler, LA | 1 |
| Bagheri-Yarmand, R; Kumar, R; Talukder, AH; Vadlamudi, RK; Wang, RA | 1 |
| Dziegiel, P; Kanzawa, H; Madej, JA; Nowak, M | 1 |
| Meistrich, ML; Pollack, A; Terry, NH; White, RA; Wise, BM; Wu, CS | 1 |
| Cho, MY; Jang, TJ; Kim, JR; Park, JH | 1 |
7 other study(ies) available for bromodeoxyuridine and Animal Mammary Carcinoma
| Article | Year |
|---|---|
Mechanistic approach of contrasting modifying effects of caffeine on carcinogenesis in the rat colon and mammary gland induced with 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.
Topics: Animals; Antimetabolites, Antineoplastic; Blotting, Western; Body Weight; Breast; Bromodeoxyuridine; Caffeine; Carcinogens; Central Nervous System Stimulants; Colon; Colonic Neoplasms; Cytochrome P-450 CYP1A2; DNA Adducts; DNA Repair; DNA, Single-Stranded; Female; Imidazoles; Immunohistochemistry; Liver; Mammary Neoplasms, Animal; Organ Size; Rats; Rats, Inbred F344; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2003 |
Validation of the use of proliferation markers in canine neoplastic and non-neoplastic tissues: comparison of KI-67 and proliferating cell nuclear antigen (PCNA) expression versus in vivo bromodeoxyuridine labelling by immunohistochemistry.
Topics: Animals; Bromodeoxyuridine; Cell Division; Dog Diseases; Dogs; Female; Immunohistochemistry; Ki-67 Antigen; Lymphoma; Mammary Neoplasms, Animal; Proliferating Cell Nuclear Antigen | 2003 |
Prolactin induces ERalpha-positive and ERalpha-negative mammary cancer in transgenic mice.
Topics: Animals; Apoptosis; Bromodeoxyuridine; Carrier Proteins; Cell Division; Cell Lineage; Estrogen Receptor alpha; Female; Lipocalin-2; Lipocalins; Mammary Neoplasms, Animal; Mice; Mice, Transgenic; Mitosis; Phenotype; Prolactin; Promoter Regions, Genetic; Rats; Receptors, Estrogen; Reverse Transcriptase Polymerase Chain Reaction; Time Factors; Transgenes | 2003 |
Metastasis-associated protein 1 deregulation causes inappropriate mammary gland development and tumorigenesis.
Topics: Animals; bcl-X Protein; Blotting, Northern; Blotting, Southern; Bromodeoxyuridine; Cell Division; Cyclin D1; Female; Gene Expression Regulation, Developmental; Histone Deacetylases; Immunoblotting; In Situ Nick-End Labeling; Male; Mammary Glands, Animal; Mammary Neoplasms, Animal; Mice; Mice, Transgenic; Models, Genetic; Protein Isoforms; Proto-Oncogene Proteins c-bcl-2; Receptors, Progesterone; Repressor Proteins; Reverse Transcriptase Polymerase Chain Reaction; Time Factors; Trans-Activators | 2004 |
Immunohistochemical identification method of tumour cells in the S phase of mitotic cycle and its usefulness in diagnostics of mammary gland adenocarcinomas in bitches.
Topics: Adenocarcinoma; Animals; Bromodeoxyuridine; Cell Division; Dog Diseases; Dogs; Female; Immunohistochemistry; Ki-67 Antigen; Mammary Neoplasms, Animal; Mitosis; Proliferating Cell Nuclear Antigen; S Phase | 2006 |
Specific staining of iododeoxyuridine and bromodeoxyuridine in tumors double labelled in vivo: a cell kinetic analysis.
Topics: Animals; Bromodeoxyuridine; Cell Cycle; Cell Nucleus; Flow Cytometry; Idoxuridine; Mammary Neoplasms, Animal; Mice; Neoplasm Transplantation; Staining and Labeling | 1995 |
Chemically induced rat mammary tumor treated with tamoxifen showed decreased expression of cyclin D1, cyclin E, and p21(Cip1).
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Bromodeoxyuridine; Cyclin D1; Cyclin E; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Female; Gene Expression; Mammary Neoplasms, Animal; Rats; Rats, Sprague-Dawley; Tamoxifen; Treatment Outcome | 2001 |